Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Celgene in Third Discovery and Development Pact | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Evotec, Celgene in Third Discovery and Development Pact

Will leverage Evotec's Panomics platform to identify drug targets that are traditionally difficult to track

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec and Celgene Corp. have entered into a third strategic drug discovery and development partnership in the field of targeted protein degradation.

In this collaboration, the companies will leverage Evotec’s Panomics platform to identify drug targets that are traditionally difficult to track. Evotec’s Panomics platform applies high-end proteomics and transcriptomics at industrial scale to profile and select promising drug candidates on the basis of comprehensive cell biological profiles. The platform also includes an integrated data analytics platform, “PanHunter”, which facilitates the analysis and interpretation of large ‘omics’ data sets.

The collaboration will leverage Evotec’s proteomics experts at its sites in Munich, Germany, and Toulouse, France. Evotec will receive an undisclosed upfront payment as well as milestones and royalties on each licensed program. Celgene holds exclusive rights for all programs resulting from this collaboration.

Dr. Cord Dohrmann, chief scientific officer of Evotec, said, “We are very excited to enter into this third partnership with Celgene, opening opportunities to expand beyond neurodegeneration and oncology. Addressing traditionally undrugable targets via targeted protein degradation is a highly attractive and promising approach which has not been explored systematically.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics